BIBR 1087 SE is primarily utilized in research settings as a selective inhibitor of thrombin, a key enzyme involved in the blood coagulation process. Its application is significant in studies focused on understanding and modulating thrombotic events, which are crucial in conditions like deep vein thrombosis, pulmonary embolism, and stroke. Researchers employ this compound to explore potential therapeutic strategies for preventing blood clots without excessively increasing the risk of bleeding, a common limitation with traditional anticoagulants. Additionally, BIBR 1087 SE is used in pharmacological studies to investigate the role of thrombin in various cellular processes, including inflammation and cell proliferation, providing insights into its broader physiological and pathological roles.